Related Experiment Video
Updated: Nov 11, 2025
11:05
Analysis of Oxidative Stress in Zebrafish Embryos
Published on: July 7, 2014
37.7K
Nrf2 a molecular therapeutic target for Astaxanthin
Zeynab Kohandel1, Tahereh Farkhondeh2, Michael Aschner3
1Department of Biology, Faculty of Sciences, University of Tehran, Iran.
Summary
Astaxanthin (ATX), a potent antioxidant, demonstrates significant anti-cancer, anti-aging, and protective effects across multiple organs. Its benefits are largely mediated by the Nrf2 pathway, highlighting its therapeutic potential.
Area of Science:
- Nutritional Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Astaxanthin (ATX) is a natural carotenoid pigment found in various marine organisms.
- ATX is recognized for its potent antioxidant capabilities.
- Emerging research indicates ATX possesses anti-inflammatory, anti-apoptotic, and anti-proliferative activities.
Purpose of the Study:
- To review the multifaceted health benefits of Astaxanthin.
- To elucidate the role of Nuclear factor erythroid 2-related factor 2 (Nrf2) in mediating ATX's effects.
- To consolidate evidence for ATX's protective roles in various physiological systems.
Main Methods:
- Literature review of existing scientific studies on Astaxanthin.
- Analysis of research focusing on the Nrf2 signaling pathway.
- Synthesis of data regarding ATX's impact on cellular and organ protection.
Main Results:
- Astaxanthin exhibits significant antioxidant and anti-inflammatory properties.
- Nrf2 activation is a key mechanism underlying ATX's therapeutic effects.
- ATX demonstrates protective benefits for the brain, lungs, skin, heart, liver, and muscles, and shows potential in anti-diabetic and anti-aging applications.
Conclusions:
- Astaxanthin is a promising nutraceutical with broad-spectrum health benefits.
- The Nrf2 pathway is crucial for mediating the protective effects of Astaxanthin.
- Further research into ATX and Nrf2 interactions could lead to novel therapeutic strategies.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
8.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.5K
01:31Transducer Mechanism: Nuclear Receptors
2.0K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.0K
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
01:46Electron Transport Chain: Complex I and II
16.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
16.6K